1 min read

ID: 131406

Discovery Date: 13 May 2022, 09:55:08 UTC

Published Date: NaT

Source: European Clinical Trials Register

Link: https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2012-003056-36

Abstract

EudraCT Number: 2012-003056-36
Sponsor Protocol Number: CBAF312A2304
Sponsor Name: Novartis Pharma Services AG
Start Date: 2012-10-31
Medical condition: Secondary progressive multiple sclerosis
Disease:
Version: 21.1
SOC Term: 10029205 - Nervous system disorders
Classification Code: 10063400
Term: Secondary progressive multiple sclerosis
Level: PT

Population Age: Adults
Gender: Male, Female
Trial Protocol: HU (Ongoing), IE (Ongoing), DE (Ongoing), CZ (Ongoing), SK (Completed), NL (Ongoing), ES (Ongoing), GB (GB - no longer in EU/EEA), AT (Ongoing), SE (Ongoing), PT (Ongoing), IT (Ongoing), LV (Ongoing), GR (Ongoing), LT (Ongoing), EE (Ongoing), BE (Ongoing), PL (Ongoing), BG (Ongoing), FR (Ongoing)

Noun Phrases in Title

This is an independent project that runs on the good will of volunteers

You can help by spreading the word or by donating what you can to pay for the server costs.